文献速递睡眠呼吸障碍咽喉与嗓音

腭部手术治疗阻塞性睡眠呼吸暂停围术期塞来昔布和对乙酰氨基酚与阿片类药物消耗的关联

Association Between Perioperative Celecoxib, Acetaminophen, and Opioid Consumption After Palate Surgery for Obstructive Sleep Apnea.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-11-26

本研究为回顾性队列研究,纳入2013年7月至2023年6月接受软腭手术治疗阻塞性睡眠呼吸暂停并术后住院的成人210例(女性占15.7%),分析围术期塞来昔布和对乙酰氨基酚使用与术后24小时内阿片类药物消耗(以吗啡毫克当量MME计)的关联。结果显示,塞来昔布使用与术后MME消耗减少相关(每100 mg减少2.7 ± 1.1 MME,P = .018),而对乙酰氨基酚与术后阿片类药物使用无关联(每100 mg减少0.3 ± 0.3 MME,P = .43)。

要点

  • 术后24小时平均MME消耗为80.2 ± 63.9,60%患者使用塞来昔布,93%使用对乙酰氨基酚。
  • 塞来昔布使用与术后MME消耗减少相关(每100 mg减少2.7 ± 1.1 MME,P = .018)。
  • 对乙酰氨基酚与术后阿片类药物使用无关联(每100 mg减少0.3 ± 0.3 MME,P = .43)。

核心结论

  • 围术期塞来昔布与腭部手术后24小时内MME消耗减少相关,而对乙酰氨基酚与术后阿片类药物使用无关联。

研究设计与样本

  • 回顾性队列研究,纳入2013年7月至2023年6月接受软腭手术治疗阻塞性睡眠呼吸暂停并术后住院的成人210例(女性占15.7%),平均年龄48.8 ± 37.5岁。

主要发现

  • 术后24小时平均MME消耗为80.2 ± 63.9。
  • 126例(60%)患者围术期使用塞来昔布,195例(93%)使用对乙酰氨基酚。
  • 塞来昔布使用与术后MME消耗减少相关(每100 mg减少2.7 ± 1.1 MME,P = .018)。
  • 对乙酰氨基酚与术后MME消耗无关联(每100 mg减少0.3 ± 0.3 MME,P = .43)。
  • 女性、亚洲种族和非裔美国种族也与术后MME消耗减少相关,而自身免疫/免疫抑制疾病和扁桃体切除术与MME消耗增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the effect of perioperative celecoxib and acetaminophen administration on opioid consumption in the first 24 hours after palate surgery for obstructive sleep apnea (OSA). STUDY DESIGN: Retrospective cohort study. SETTING: Tertiary academic center. METHODS: Adults with OSA undergoing soft palate surgery and admitted to the hospital postoperatively between July 2013 and June 2023 were included. Study participants were also included if they underwent concurrent nasal surgery but excluded if they underwent any pharyngeal surgery other than tonsillectomy or were taking opioids prior to surgery. Opioids administered after surgery were converted to morphine milligram equivalents (MME). Multiple linear regression was used to examine the association between total MME consumed in the first 24 hours postoperatively and celecoxib and acetaminophen usage. RESULTS: A total of 210 study participants (15.7% female) were included with a mean age of 48.8 ± 37.5 years. The mean MME consumed in the first 24 hours after palate surgery was 80.2 ± 63.9. One hundred and twenty-six (60%) study participants received perioperative celecoxib, while 195 (93%) received perioperative acetaminophen. Celecoxib use was associated with lesser MME (-2.7 ± 1.1 MME per 100 mg; P = .018) consumed postoperatively, while acetaminophen was not (-0.3 ± 0.3 MME per 100 mg; P = .43). Female gender, Asian race, and African American race were also associated with lesser MME consumed postoperatively, while autoimmune/immunosuppressive conditions and tonsillectomy were associated with greater MME consumption. CONCLUSION: Perioperative celecoxib was associated with reduced MME consumption in the first 24 hours after palate surgery. No association was found between acetaminophen and postoperative opioid use.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Badash I, Wong S, Biju K, et al. Association Between Perioperative Celecoxib, Acetaminophen, and Opioid Consumption After Palate Surgery for Obstructive Sleep Apnea. Otolaryngol Head Neck Surg. 2024. PMID: 39588650. doi:10.1002/ohn.1069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。